Literature DB >> 26330228

Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort.

Jasvinder A Singh1,2,3,4,5, Kasem S Akhras6, Aki Shiozawa6.   

Abstract

Entities:  

Year:  2015        PMID： 26330228      PMCID： PMC4557853          DOI： 10.1186/s13075-015-0752-9

Source DB:  PubMed          Journal:  Arthritis Res Ther        ISSN： 1478-6354            Impact factor:   5.156


× No keyword cloud information.
Unfortunately, the original version of this article [1] contained an error. The Fig. 1 was included incorrectly. The correct Fig. 1 can be found below.
Fig. 1

ᅟ

ᅟ
  1 in total

1.  Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort.

Authors:  Jasvinder A Singh; Kasem S Akhras; Aki Shiozawa
Journal:  Arthritis Res Ther       Date:  2015-05-12       Impact factor: 5.156
  1 in total
  1 in total

Review 1.  Review of Urate-Lowering Therapeutics: From the Past to the Future.

Authors:  Christopher Jenkins; Jennifer H Hwang; Jeffrey B Kopp; Cheryl A Winkler; Sung Kweon Cho
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.